Clinical Trials Browser

INDUSTRY × nintedanib × Other solid neoplasm × Clear all

NCT01907100 2019-03-18

Nintedanib (BIBF 1120) in Mesothelioma

Phase 2/3 Terminated

545 enrolled 15 charts

Other solid neoplasmThoracic

Mesothelioma

NCT01951846 2013-09-27

To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid Tumours

Phase 1 Completed

Other solid neoplasm

Malignant Solid Tumour